The European Union on Wednesday slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the 27-nation bloc’s antitrust watchdog, the latest setback for the deal.
Illumina announced a $7.1 billion acquisition of Grail in 2020, but the European Commission, the EU’s executive arm, said the company broke the bloc’s merger rules by completing the deal without its consent. The EU had announced last year that it was blocking the merger, saying it would hurt competitors.
San Diego-based Illumina is a major supplier of next-generation sequencing systems for genetic and genomic analysis, while Grail is a health company developing blood tests to try to catch cancer early. The commission says companies almost invariably play by the rules and wait to complete an acquisition or merger until antitrust authorities have cleared it.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
EU fines US firm Illumina $475 million for jumping gun on buyout of cancer-screening company GrailThe European Union slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the EU's antitrust watchdog. Last year, the EU blocked the $7.1 billion merger on competition grounds.
Leer más »
Illumina Fined More Than $400 Million in Europe for Closing Grail Deal EarlyThe European Union’s antitrust watchdog fined the company with the maximum allowable amount for wrapping up its acquisition of the cancer-test developer while the agency was still reviewing it.
Leer más »
Illumina hit with record fine for closing Grail deal without EU regulatory approvalThe European Commission last year blocked Illumina's $7.1 billion acquisition of Grail over concerns it would stifle innovation and consumer choice.
Leer más »
Illumina Fined More Than $400 Million in Europe for Closing Grail Deal EarlyBy Kim Mackrael BRUSSELS--The European Union has fined Illumina more than $400 million for proceeding with its acquisition of cancer-test developer Grail...
Leer más »
Illumina to face record EU antitrust fine for Grail deal, source saysU.S. genetic testing company Illumina will face a record EU antitrust fine on Wednesday for closing its takeover of Grail before it secured approval from EU regulators, a person familiar with the matter said on Tuesday.
Leer más »
LIHEAP payments: Direct payment worth up to $475 to help Arkansas residents with utility bills arrives todayArkansas residents in several counties who were approved for the Low Income Home Energy Assistance Program can expect benefit payments to arrive on Monday.
Leer más »